The pre-mRNA splicing pathway is highly conserved from yeast (S. cerevisiae) to mammals. Of the four snRNPs involved in splicing three (Ul, U2 and U4/U6) have been shown to be essential for in vitro splicing. To examine the remaining snRNP, we utilized our previously described genetic procedures (Seraphin and Rosbash, 1989) to prepare yeast extracts depleted of U5 snRNP. The results show that U5 snRNP is necessary for both steps of pre-mRNA splicing and for proper spliceosome assembly, i.e., addition of the U4/U5/U6 triple snRNP. The prior steps of Ul and U2 snRNP addition occur normally in the absence of U5 snRNP.
INTRODUCTION
The process of pre-mRNA splicing is highly conserved from yeast to mammals (1, 2) . Many of the trans-acting factors required for splicing are also conserved, and these include the four snRNPs (U1, U2, U4/U6, and U5) (3) that associate with the pre-mRNA during the spliceosome assembly process, much of which precedes the first cleavage and ligation reaction (4) (5) (6) (7) (8) (9) (10) (11) (12) . U1, U2 and U4/U6 have been shown to be essential for in vitro splicing and have been assigned a specific role in spliceosome assembly (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) .
The role of U5 snRNP is less clearly defined. On the one hand, it has been suggested that an early step in spliceosome assembly might consist of 3' splice site recognition by U5 snRNP (26) . On the other, two different studies (an in vivo study in yeast and an in vitro study in fractionated Hela extracts), have raised the possibility that U5 snRNP might not be essential for the first step of splicing, 5' splice site cleavage and lariat formation (27, 28) . The relatively indirect approaches used to date are due, at least in part, to the fact that active U5 snRNP is difficult to remove from splicing extracts. This is because it is refractory to the normal oligonucleotide hybridization procedures necessary for targeted RNAse H digestion or for antisense depletion procedures (29 (21) . Splicing assays, and native gel electrophoresis were as described (21) . Procedures for streptavidin affinity selection of splicing complexes formed on biotinylated substrates as well as subsequent snRNA analysis have also been previously described (25) .
RESULTS
We constructed a yeast strain containing a disrupted chromosomal copy of the yeast U5 gene complemented by a plasmid containing a U5 snRNA transcription unit under the control of the Gal-10 upstream activator sequence (Gal-U5). As previously described for similar Gal-U1 and Gal-U2 constructs (21, 30) , switching carbon sources from galactose to glucose repressed transcription from the Gal-U5 gene. Yet cell growth continued for 16 h (and was normal for at least 10 h), during which time the U5 snRNA content was diluted substantially (27) (data not shown).
In extracts derived from these depleted cells (AU5 extracts), US snRNA is undetectable, indicating that there is less than 5% of the wild type level of Centrifugation of a wild-type extract under moderate salt conditions leads to a partitioning of yeast snRNPs between pellet and supernatant fractions (25) (Figure 1 , compare lanes 5 and 9). Depletion of U 1 or U2 snRNP had only a modest effect on the distribution of the remaining snRNAs between the pellet and supernatant fractions (Figure 1, lanes 6,7,10 and 1 1) . In a AU5 extract, however, a major change was readily visible; all of the U4 and U6 snRNAs were in the supernatant fraction ( Figure 1,  lanes 8 and 12) . This observation suggests that the U4/U6 snRNP present in the pellet fraction was associated with U5 snRNP in a U4/U5/U6 triple snRNP particle and that the U4/U6 snRNP present in the supernatant fraction was free U4/U6 snRNP. Depletion of U5 snRNP thus resulted in loss of the U4/U5/U6 triple snRNP particle (Figure 1, lanes 5 and 8) .
Like the AUI and AU2 extracts, AU5 extracts made from cells depleted of U5 snRNA for 5, 10, or 16 h (U5 -5; U5 -lO; U5-16) supported little or no in vitro splicing (Figure 2 , lanes 1-6). Depletion for 5 h, estimated to reduce U5 snRNP levels 5-fold (data not shown), was insufficient to eliminate splicing (lane 4) whereas no splicing was detected in the extracts depleted for 10 and 16 h (lanes 5 and 6, respectively). The AU5-10 extract was able to complement the AU1 and the AU2 extracts (lanes 8 and 9) almost to the same extent that the AU1 and AU2 extracts were able to complement each other (lane 7). A less efficient complementation was also observed for the AU5-16 extract (data not shown). Spliceosome assembly was also significantly reduced in the zAU5 extracts (AU5-16< AU5-1O< AU5-5; Figure 3 , lanes 2-4). Yet U2 snRNP addition to the substrate still occurred as the complexes that formed in these depleted extracts have been previously shown to contain U2 snRNP (21) . Also, oligonucleotide-directed RNase H digestion of U2 snRNA in the AUS extracts resulted in the disap-pearance of these complexes and the appearance of commitment complexes (21, 31) , the Ul snRNP-containing complexes that form prior to the addition of U2 snRNP (CC; Figure 3 , lane 6 and data not shown). Significantly, no CC accumulation was detectable in the AU5 extracts, indicating that U2 snRNP addition was efficient enough to convert all of the commitment complexes to prespliceosome complexes.
The analysis could not, however, assess the addition of U4/U6 snRNP. (This is because in this system some of these presplicing complexes also contain Ul snRNP; as yeast Ul and U2 snRNAs are so much larger than U4, U5, and U6 snRNAs, complexes that contain U4/U6 snRNP are not well resolved from those that lack it (21)(data not shown). As a consequence, we assayed U6 snRNP addition by affinity selection of the pre-mRNA substrate (Figure 4) . In a AU5 extract, U6 snRNP addition was not detected ( Figure 4A, lane 1) , i.e., the levels were comparable to what was detected with a control (splicing-incompetent) substrate (lane 2) or with mutant extracts in which U2 snRNP addition activity (prp9, lane 4), or U4/U6 snRNP activity (prp6 and prp 4, lanes 5 and 6, respectively), had been heat inactivated (25) . U2 snRNP addition was assayed in parallel with the expected results, namely, that only the extract in which U2 snRNP activity had been inactivated (lane 4) and the control substrate (lane 2) were defective for U2 snRNP addition. Results with a AU2 extract were identical to those obtained by heat inactivating the prp9 strain (25) .
As expected from the splicing complementation results (Figure 2 ), the addition of a second depleted (or mutant) extract was able to complement the U6 addition defect of the AU5 extract ( Figure 4B ). This was true for a AU2 extract (lane 3) as well as an inactivated prp9 extract (lane 4) and inactivated prp6 and prp4 extracts (lanes 5 and 6, respectively). (18) . The splicing complexes (SP) and the committment complexes (CC) were resolved on native gels (21 (32) .
Previous in vivo work in the yeast system indicated that depletion or inactivation of U5 snRNP lead to a severe inhibition of splicing (27, 33) . More recently, Newman and Norman uncovered mutations in U5 snRNA that supressed a 5' splice site mutation (34) . These observations suggest that U5 snRNP is important for the first step of splicing, consistent with the results reported here.
In the study that examined the consequences of U5 snRNP depletion (27) , there was some increase in lariat intermediate which lead the authors to speculate that U5 snRNP might not be essential for the first step of splicing. A previous in vitro study in the mammalian system also suggested that U5 snRNP may not be essential for the first step of splicing (28) . We suspect that these two observations were due to the pleiotropic in vivo effects of these depletion protocols on the one hand (27) , and to the incomplete elimination of U5 snRNP from the in vitro experiments on the other (28) . In any case, none of these studies identified the step at which spliceosome assembly was inhibited.
Our results indicate that the absence of U5 snRNP prevents U4 \ U6 snRNP addition, i.e., U4 \ U5 \ U6 snRNP are added together as a triple snRNP. As Ul and U2 snRNP addition occur normally, it would appear that the U5 snRNP plays no role in the early steps of splice site recognition and spliceosome assembly. This conclusion argues against the interpretation of some earlier work in mammalian systems (26) . Taken together with studies that examined the effects of depleting or inactivating the other three splicing snRNPs, our results indicate that several central features of the spliceosome assembly pathway are conserved from yeast to man. These include the formation of a U2 snRNP-pre-mRNA complex and the subsequent formation of a U4/U5/U6 snRNP-U2 snRNP-pre-mRNA complex (A-B) (8, 9, 35) . For yeast, there is additional evidence for the formation of a Ul snRNP-pre-mRNA commitment complex (CC) that precedes U2 snRNP addition (18, 20, 21, 31) , indicating a more complex pathway (CC-A-B) .
In both systems, there are many undefined features of these complexes as well as evidence for additional assembly steps that are likely to reflect the addition or removal of multiple proteins, conformational changes, and/or the progressive weakening (or tightening) of snRNP and non-snRNP factors. For example, the relationship of Ul snRNP to both the A and B complexes is not well established (e.g., (11, 12) ), and the structure of the U4/U6 snRNP probably undergoes a substantial change during spliceosome assembly (6, 8, 9, 11, 36) . As the core snRNP contents of the A and B complexes are unlikely to be altered by these ambiguities and spliceosome changes, we suggest that the resulting complexes be referred to as subcomplexes (e.g., Al, A2, Bi, etc.) and that, where appropriate, the mammalian
